Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà
MedNavigator.ru - Ïîèñê è ïîäáîð ëå÷åíèÿ â Ðîññèè è çà ðóáåæîì

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Ïåäèàòðèÿ > Âàêöèíîïðîôèëàêòèêà

Îòâåò
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #1  
Ñòàðûé 12.06.2011, 21:13
Àâàòàð äëÿ luidhen
luidhen luidhen âíå ôîðóìà ÂÐÀ×
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 10.11.2010
Ãîðîä: ×åëÿáèíñê
Ñîîáùåíèé: 9,055
Ñêàçàë(à) ñïàñèáî: 40
Ïîáëàãîäàðèëè 4,301 ðàç(à) çà 4,154 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 3
luidhen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåluidhen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåluidhen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåluidhen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåluidhen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåluidhen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåluidhen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåluidhen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåluidhen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåluidhen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåluidhen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
10 çàâåòîâ èììóíèçàöèè

• Íå îòêàçûâàé â âàêöèíàöèè íè îäíîìó ðåáåíêó, èáî âñå äåòè èìåþò ïðàâî íà çàùèòó îò áîëåçíåé.

• Ïðîñâåòëÿé óìû òåõ, êòî íå èñïîëíÿåò ñâîåãî äîëãà ïî çàùèòå ïîòîìñòâà îò èíôåêöèé.

• Ïåðåä âàêöèíàöèåé çàðó÷èñü ñîãëàñèåì ñâîåãî ïàöèåíòà.

• Îòíîñèñü ê âàêöèíàì ïî÷òèòåëüíî, ñ áëàãîãîâåíèåì è îáðàùàéñÿ ñ íèìè áåðåæíî.

• Íå áîéñÿ îäíîâðåìåííîãî ââåäåíèÿ íåñêîëüêèõ âàêöèí.

• Íèêîãäà íå óìåíüøàé ðåêîìåíäóåìîé äîçû.

• Íå íà÷èíàé êóðñ âàêöèíàöèè çàíîâî, åñëè êàêàÿ-ëèáî èç äîç áûëà ââåäåíà ñ çàïîçäàíèåì.

• Íå îòêëàäûâàé íà çàâòðà âàêöèíàöèþ, êîòîðàÿ ìîãëà áûòü ïðîâåäåíà ñåãîäíÿ.

• Áóäü îòêðûò ê èçìåíåíèÿì â êàëåíäàðå ïðèâèâîê è ïðèäåðæèâàéñÿ ðåêîìåíäóåìûõ ñïåöèàëèñòàìè ñõåì âàêöèíàöèè.

• Íå çàáûâàé òåõ äíåé, êîãäà òâîè ïðåäêè ñòðàäàëè îò áîëåçíåé â îòñóòñòâèè âàêöèí.


Dr. Thomas Nick Saari

Êîììåíòàðèè ê ñîîáùåíèþ:
cactus1972 îäîáðèë(à): ñêîðåé óæ - 10 çàïîâåäåé)))
Annabella îäîáðèë(à): À ÷òî äåëàòü ïðè îòñóòñòâèè âîçìîæíîñòè ïðîñâåòëåíèÿ?
Îòâåòèòü ñ öèòèðîâàíèåì
  #2  
Ñòàðûé 02.03.2012, 21:06
axt axt âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 03.08.2011
Ãîðîä: Ðîñòîâ-íà-Äîíó
Ñîîáùåíèé: 42
Ñêàçàë(à) ñïàñèáî: 12
axt *
> Íå áîéñÿ îäíîâðåìåííîãî ââåäåíèÿ íåñêîëüêèõ âàêöèí.

À êàê æå

Ñîâðåìåííûå ïðîáëåìû âàêöèíîïðîôèëàêòèêè òóáåðêóëåçà

Æ.È. Êðèâîøååâà,Í.Ñ. Ìîðîçêèíà,Ï.Ñ. Êðèâîíîñ
Áåëîðóññêèé ãîñóäàðñòâåííûé ìåäèöèíñêèé óíèâåðñèòåò


Ïðè èçó÷åíèè ðîññèéñêèìè ó÷åíûìè (Åôèìîâà À.À. ñ ñîàâò.) ãóìîðàëüíûõ ïîêàçàòåëåé êðîâè íîâîðîæäåííûõ äî è ïîñëå âàêöèíàöèè ÁÖÆ óñòàíîâëåíî, ÷òî ñâîáîäíûé ãèñòàìèí â ñûâîðîòêå êðîâè äåòåé äî ââåäåíèÿ âàêöèíû íå îáíàðóæèâàëñÿ, íî ÷åðåç 9-10 äíåé ïîñëå âàêöèíàöèè ñîäåðæàíèå ãèñòàìèíà â êðîâè çàìåòíî âîçðàñòàëî. Ïîêàçàòåëü ãèñòàìèíîñâÿçûâàþùåé ñïîñîáíîñòè ñûâîðîòêè êðîâè îñòàâàëñÿ íèçêèì èëè íóëåâûì â òå÷åíèå 2-3 ìåñÿöåâ, ó äåòåé ñ àëëåðãè÷åñêèìè çàáîëåâàíèÿìè – è áîëåå äëèòåëüíûé ñðîê, ÷òî ñîïðîâîæäàëîñü óñèëåíèåì ñèìïòîìîâ àëëåðãèè èëè âîçíèêíîâåíèåì èíòåðêóððåíòíûõ çàáîëåâàíèé. Âàêöèíàëüíûé ïðîöåññ ïîñòåïåííî íàðàñòàåò â òå÷åíèå 2-3 ìåñÿöåâ.  ýòî âðåìÿ ðåáåíêà âàêöèíèðóþò ïîâòîðíî â 1 ìåñÿö ïðîòèâ ãåïàòèòà  è â 3 ìåñÿöà åùå ïðîòèâ 4 èíôåêöèé äâóìÿ âàêöèíàìè, íå ïðèíèìàÿ âî âíèìàíèå ñòàäèþ ìåñòíîé ðåàêöèè íà ââåäåíèå âàêöèíû ÁÖÆ. Îïðåäåëåííàÿ ÷àñòü îñëîæíåíèé ñâÿçàíà êàê ðàç ñ ïðîâåäåíèåì äðóãèõ ïðèâèâîê íà ôîíå ëîêàëèçîâàííîãî, íî àêòèâíîãî òóáåðêóëåçíîãî ïðîöåññà â êîæå íà ìåñòå ââåäåíèÿ âàêöèíû ÁÖÆ [20].

20. Òóáåðêóëåç ó äåòåé è ïîäðîñòêîâ: ðóêîâîäñòâî / ïîä ðåä. Î. È. Êîðîëü, Ì. Ý. Ëîçîâñêîé. ÑÏá: Ïèòåð, 2005. 432 ñ.

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Îòâåòèòü ñ öèòèðîâàíèåì
  #3  
Ñòàðûé 02.03.2012, 21:39
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,358
Ïîáëàãîäàðèëè 33,212 ðàç(à) çà 31,562 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò axt Ïîñìîòðåòü ñîîáùåíèå
> Íå áîéñÿ îäíîâðåìåííîãî ââåäåíèÿ íåñêîëüêèõ âàêöèí.

À êàê æå

Ñîâðåìåííûå ïðîáëåìû âàêöèíîïðîôèëàêòèêè òóáåðêóëåçà

Æ.È. Êðèâîøååâà,Í.Ñ. Ìîðîçêèíà,Ï.Ñ. Êðèâîíîñ
Áåëîðóññêèé ãîñóäàðñòâåííûé ìåäèöèíñêèé óíèâåðñèòåò


Ïðè èçó÷åíèè ðîññèéñêèìè ó÷åíûìè (Åôèìîâà À.À. ñ ñîàâò.) ãóìîðàëüíûõ ïîêàçàòåëåé êðîâè íîâîðîæäåííûõ äî è ïîñëå âàêöèíàöèè ÁÖÆ óñòàíîâëåíî, ÷òî ñâîáîäíûé ãèñòàìèí â ñûâîðîòêå êðîâè äåòåé äî ââåäåíèÿ âàêöèíû íå îáíàðóæèâàëñÿ, íî ÷åðåç 9-10 äíåé ïîñëå âàêöèíàöèè ñîäåðæàíèå ãèñòàìèíà â êðîâè çàìåòíî âîçðàñòàëî. Ïîêàçàòåëü ãèñòàìèíîñâÿçûâàþùåé ñïîñîáíîñòè ñûâîðîòêè êðîâè îñòàâàëñÿ íèçêèì èëè íóëåâûì â òå÷åíèå 2-3 ìåñÿöåâ, ó äåòåé ñ àëëåðãè÷åñêèìè çàáîëåâàíèÿìè – è áîëåå äëèòåëüíûé ñðîê, ÷òî ñîïðîâîæäàëîñü óñèëåíèåì ñèìïòîìîâ àëëåðãèè èëè âîçíèêíîâåíèåì èíòåðêóððåíòíûõ çàáîëåâàíèé. Âàêöèíàëüíûé ïðîöåññ ïîñòåïåííî íàðàñòàåò â òå÷åíèå 2-3 ìåñÿöåâ.  ýòî âðåìÿ ðåáåíêà âàêöèíèðóþò ïîâòîðíî â 1 ìåñÿö ïðîòèâ ãåïàòèòà  è â 3 ìåñÿöà åùå ïðîòèâ 4 èíôåêöèé äâóìÿ âàêöèíàìè, íå ïðèíèìàÿ âî âíèìàíèå ñòàäèþ ìåñòíîé ðåàêöèè íà ââåäåíèå âàêöèíû ÁÖÆ. Îïðåäåëåííàÿ ÷àñòü îñëîæíåíèé ñâÿçàíà êàê ðàç ñ ïðîâåäåíèåì äðóãèõ ïðèâèâîê íà ôîíå ëîêàëèçîâàííîãî, íî àêòèâíîãî òóáåðêóëåçíîãî ïðîöåññà â êîæå íà ìåñòå ââåäåíèÿ âàêöèíû ÁÖÆ [20].

20. Òóáåðêóëåç ó äåòåé è ïîäðîñòêîâ: ðóêîâîäñòâî / ïîä ðåä. Î. È. Êîðîëü, Ì. Ý. Ëîçîâñêîé. ÑÏá: Ïèòåð, 2005. 432 ñ.

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Ðîññèéñêèì ó÷åíûì â ëèöå Åôèìîâîé À.À. ñ ñîàâò. íóæíî áûëî ïèñàòü äèññåð, äëÿ òîãî ÷òîáû åãî çàùèòèòü, à äëÿ çíà÷èìîñòè ñâîåé ðàáîòû îíè ñäåëàëè âûâîäû, êîòîðûå íå ñîîòâåòñòâóþò ðåàëüíîé äåéñòâèòåëüíîñòè, äðóãèå èì ïîäîáíûå ñ óäîâîëüñòâèåì ïåðåïå÷àòûâàþò ñèè ï¸ðëû â ñàìèçäàòîâñêèå êíèæêè, êàôåäðàëüíûå ìåòîäè÷êè è ïàðÿò èìè íåîêðåïøèé ìîñê ñòóäåíòîâ, ìîëîäûõ äîêòîðîâ è ïðîñòî îáûâàòåëåé
.
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #4  
Ñòàðûé 02.03.2012, 21:53
axt axt âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 03.08.2011
Ãîðîä: Ðîñòîâ-íà-Äîíó
Ñîîáùåíèé: 42
Ñêàçàë(à) ñïàñèáî: 12
axt *
Ò.å. åñòü èññëåäîâàíèÿ, îïðîâåðãàþùèå Åôèìîâó è Êîðîëÿ?
Îòâåòèòü ñ öèòèðîâàíèåì
  #5  
Ñòàðûé 02.03.2012, 22:04
Àâàòàð äëÿ luidhen
luidhen luidhen âíå ôîðóìà ÂÐÀ×
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 10.11.2010
Ãîðîä: ×åëÿáèíñê
Ñîîáùåíèé: 9,055
Ñêàçàë(à) ñïàñèáî: 40
Ïîáëàãîäàðèëè 4,301 ðàç(à) çà 4,154 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 3
luidhen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåluidhen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåluidhen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåluidhen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåluidhen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåluidhen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåluidhen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåluidhen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåluidhen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåluidhen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåluidhen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ìàëî òîãî (ñì. ïîñò Âàäèìà Âàëåðüåâè÷à), è êàêîå æå îòíîøåíèå ê îäíîâðåìåííîìó ââåäåíèþ íåñêîëüêèõ âàêöèí èìååò ñèå òâîðåíèå -
Îòâåòèòü ñ öèòèðîâàíèåì
  #6  
Ñòàðûé 02.03.2012, 22:05
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,358
Ïîáëàãîäàðèëè 33,212 ðàç(à) çà 31,562 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ñïåöèàëüíî äëÿ Âàñ:

4. When appropriate, all indicated vaccines should be administered simultaneously (B-III).

If >1 vaccine is recommended to be administered at a specific age, vaccines should be administered at the same visit at separate injection sites. Simultaneously administering all vaccines to a person who is eligible is important, because simultaneous administration increases the probability that a child or adult will be appropriately immunized [23]. ...Simultaneously administering different combinations of live and inactivated vaccines has resulted in seroconversion rates similar to rates observed when the vaccines are administered separately [22].

èñòî÷íèê ïîëíîãî òåêñòà çäåñü (òàì æå ññûëêè íà ïåðâîèñòî÷íèêè): [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Êîììåíòàðèè ê ñîîáùåíèþ:
luidhen îäîáðèë(à):
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #7  
Ñòàðûé 03.03.2012, 09:34
axt axt âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 03.08.2011
Ãîðîä: Ðîñòîâ-íà-Äîíó
Ñîîáùåíèé: 42
Ñêàçàë(à) ñïàñèáî: 12
axt *
Áëàãîäàðþ.

 òåõ æå "Ñîâðåìåííûõ ïðîáëåìàõ..." çàìàõèâàþòñÿ è íà øåñòîé ïóíêò çàâåòîâ:

Èñïîëüçîâàíèå âàêöèíû ÁÖÆ-Ì ñî ñíèæåííîé àíòèãåííîé íàãðóçêîé ïîçâîëèëî óìåíüøèòü ÷èñëî ÁÖÆ-ëèìôàäåíèòîâ â 3-5 ðàç [2, 14].

Âñå âûøåóêàçàííîå ïîçâîëÿåò ïðåäëîæèòü ìåðîïðèÿòèÿ, êîòîðûå, ïî íàøåìó ìíåíèþ, ïîâûñÿò ýôôåêòèâíîñòü è ñíèçÿò ðèñê ðàçâèòèÿ îñëîæíåíèé âàêöèíàöèè ÁÖÆ:
- áîëåå øèðîêàÿ (èëè ñïëîøíàÿ) ùàäÿùàÿ èììóíèçàöèÿ âàêöèíîé ÁÖÆ-Ì.

2. Àêñåíîâà, Â. À. Ñîâðåìåííûå ïîäõîäû ê âàêöèíàöèè ïðîòèâ òóáåðêóëåçà [Ýëåêòðîííûé ðåñóðñ].
14. Ëåãî÷íûé è âíåëåãî÷íûé òóáåðêóëåç: Ðóêîâîäñòâî äëÿ âðà÷åé / ïîä ðåä. À. Â. Âàñèëüåâà. ÑÏá., 2007.

Äàííàÿ ðåêîìåíäàöèÿ òàêæå íåêîððåêòíà?
Îòâåòèòü ñ öèòèðîâàíèåì
  #8  
Ñòàðûé 03.03.2012, 09:42
axt axt âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 03.08.2011
Ãîðîä: Ðîñòîâ-íà-Äîíó
Ñîîáùåíèé: 42
Ñêàçàë(à) ñïàñèáî: 12
axt *
Öèòàòà:
Ñîîáùåíèå îò luidhen Ïîñìîòðåòü ñîîáùåíèå
Ìàëî òîãî (ñì. ïîñò Âàäèìà Âàëåðüåâè÷à), è êàêîå æå îòíîøåíèå ê îäíîâðåìåííîìó ââåäåíèþ íåñêîëüêèõ âàêöèí èìååò ñèå òâîðåíèå -
Èñêëþ÷èòåëüíî â ðàñøèðåííîì òîëêîâàíèè. Îäíîâðåìåííàÿ ðåàêöèÿ îðãàíèçìà íà äâå âàêöèíû.
Îòâåòèòü ñ öèòèðîâàíèåì
  #9  
Ñòàðûé 03.03.2012, 19:57
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,358
Ïîáëàãîäàðèëè 33,212 ðàç(à) çà 31,562 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò axt Ïîñìîòðåòü ñîîáùåíèå
Áëàãîäàðþ.

 òåõ æå "Ñîâðåìåííûõ ïðîáëåìàõ..." çàìàõèâàþòñÿ è íà øåñòîé ïóíêò çàâåòîâ:

Èñïîëüçîâàíèå âàêöèíû ÁÖÆ-Ì ñî ñíèæåííîé àíòèãåííîé íàãðóçêîé ïîçâîëèëî óìåíüøèòü ÷èñëî ÁÖÆ-ëèìôàäåíèòîâ â 3-5 ðàç [2, 14].

Âñå âûøåóêàçàííîå ïîçâîëÿåò ïðåäëîæèòü ìåðîïðèÿòèÿ, êîòîðûå, ïî íàøåìó ìíåíèþ, ïîâûñÿò ýôôåêòèâíîñòü è ñíèçÿò ðèñê ðàçâèòèÿ îñëîæíåíèé âàêöèíàöèè ÁÖÆ:
- áîëåå øèðîêàÿ (èëè ñïëîøíàÿ) ùàäÿùàÿ èììóíèçàöèÿ âàêöèíîé ÁÖÆ-Ì.

2. Àêñåíîâà, Â. À. Ñîâðåìåííûå ïîäõîäû ê âàêöèíàöèè ïðîòèâ òóáåðêóëåçà [Ýëåêòðîííûé ðåñóðñ].
14. Ëåãî÷íûé è âíåëåãî÷íûé òóáåðêóëåç: Ðóêîâîäñòâî äëÿ âðà÷åé / ïîä ðåä. À. Â. Âàñèëüåâà. ÑÏá., 2007.

Äàííàÿ ðåêîìåíäàöèÿ òàêæå íåêîððåêòíà?
Ñíèæåíèå äîçû âàêöèíàöèè îïðåäåëåííîé âàêöèíîé (ïóíêò 6) è èñïîëüçîâàíèå áîëåå áåçîïàñíîé âàêöèíû â òîé æå äîçå (ÁÖÆ-Ì) - ÄÂÅ áîëüøèå ðàçíèöû; ïîëàãàþ, îòå÷åñòâåííûå "âàêöèíîëóõè" â ñîâåòñêîå âðåìÿ, ñòîëêíóâøèñü ñ áîëüøèì ÷èñëîì ïîñòâàêöèíàëüíûõ îñëîæíåíèé íà ÁÖÆ, ñðàâíèëè ÁÖÆ îòå÷åñòâåííîãî ðàçëèâà ñ èìïîðòíûìè àíàëîãàìè è îáíàðóæèëè, ÷òî ïîñëåäíèå ñîäåðæàò ìåíüøåå êîëè÷åñòâî îñëàáëåííûõ áàêòåðèé, íî íè÷óòü íå õóæå çàùèùàþò îò òóáåðêóëåçà. Áûñòðåíüêî ñëåïèëè ÁÖÆ-ì è ñðàâíèëè ÷àñòîòó îñëîæíåíèé:

A comparative effectiveness of the newborn BCG- and BCG-M vaccination was analysed as to the indices of primary infection, morbidity and its structure. The rate of postvaccination complications in 1,645,360 children, aged under 3 years, and living in the areas with different epidemiological situations for tuberculosis was studied too. 2,142,292 and 799486 healthy newborns were BCG- and BCG-M-vaccinated, respectively. The studies were carried out in Moscow, Kiev, Vilnius and Tashkent. The obtained results indicate that the number of complications in the form of regional lymphadenitis induced by BCG-M vaccine is 5 times less frequent than those caused by BCG.//Probl Tuberk. 1990;(12):3-5.
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #10  
Ñòàðûé 06.03.2012, 18:44
axt axt âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 03.08.2011
Ãîðîä: Ðîñòîâ-íà-Äîíó
Ñîîáùåíèé: 42
Ñêàçàë(à) ñïàñèáî: 12
axt *
Öèòàòà:
Ñîîáùåíèå îò Dr.Vad Ïîñìîòðåòü ñîîáùåíèå
Ñíèæåíèå äîçû âàêöèíàöèè îïðåäåëåííîé âàêöèíîé (ïóíêò 6) è èñïîëüçîâàíèå áîëåå áåçîïàñíîé âàêöèíû â òîé æå äîçå (ÁÖÆ-Ì) - ÄÂÅ áîëüøèå ðàçíèöû
À ðàçâå ÁÖÆ è ÁÖÆ-Ì íå îäíà è òà æå âàêöèíà â ðàçíîé äîçå?

Îäíà àìïóëà ïðåïàðàòà âàêöèíû ÁÖÆ âìåñòèìîñòüþ 2 ìë ñîäåðæèò 1 ìã ëèîôèëèçèðîâàííîãî âàêöèííîãî øòàììà ÁÖÆ-1. Ïðèâèâî÷íàÿ äîçà 0,05 ìã ïðåïàðàòà.  àìïóëå ïðåïàðàòà ÁÖÆ-Ì ñîäåðæèòñÿ 0,5 ìã âàêöèííîãî øòàììà ÁÖÆ-1, à îäíà ïðèâèâî÷íàÿ äîçà ðàâíà 0,025 ìã ïðåïàðàòà.

È ýôôåêòèâíîñòü äëÿ íåáëàãîïîëó÷íûõ ðàéîíîâ ñíèæàåòñÿ:

Under favourable epidemiological conditions, the primary infection and morbidity are alike, while under unfavourable ones the former is higher, particularly in infants in their first year as compared to the BCG-vaccinated. On the basis of the available data BCG-M can be recommended for the vaccination of all the newborns living in the areas with a favourable epidemiological situation for tuberculosis
Îòâåòèòü ñ öèòèðîâàíèåì
  #11  
Ñòàðûé 06.03.2012, 18:50
axt axt âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 03.08.2011
Ãîðîä: Ðîñòîâ-íà-Äîíó
Ñîîáùåíèé: 42
Ñêàçàë(à) ñïàñèáî: 12
axt *
Öèòàòà:
Ñîîáùåíèå îò Dr.Vad Ïîñìîòðåòü ñîîáùåíèå
If >1 vaccine is recommended to be administered at a specific age, vaccines should be administered at the same visit at separate injection sites. Simultaneously administering all vaccines to a person who is eligible is important, because simultaneous administration increases the probability that a child or adult will be appropriately immunized [23]. ...Simultaneously administering different combinations of live and inactivated vaccines has resulted in seroconversion rates similar to rates observed when the vaccines are administered separately [22].
Ïðî÷åë ïåðâîèñòî÷íèêè ïî îäíîâðåìåííîìó ââåäåíèþ âàêöèíû, êîòîðûå Âû äàëè. "With some exceptions, simultaneously administering the most widely used live and inactivated vaccines..." È äàëåå ïåðå÷èñëÿþòñÿ áåçîïàñíûå ñî÷åòàíèÿ âàêöèí, â êîòîðûõ ÁÖÆ îòñóòñòâóåò. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

È ÷èñòî àäìèíèñòðàòèâíûå çàìîðî÷êè: "and if uncertainty exists as to whether a person will return for additionally recommended vaccine doses".

Ïîëó÷àåòñÿ, ïåðâîèñòî÷íèêè Ëîçîâñêîé è Êîðîëþ íå ïðîòèâîðå÷àò, âîïðîñ òîëüêî â òîì - äîâåðÿòü ëè èì (Ë&Ê).
Îòâåòèòü ñ öèòèðîâàíèåì
  #12  
Ñòàðûé 06.03.2012, 19:06
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,358
Ïîáëàãîäàðèëè 33,212 ðàç(à) çà 31,562 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Åñëè ýòî îäíà âàêöèíà, òî òåì áîëåå á0ëüøàÿ ãëóïîñòü ðàçíîñèòü èõ â ðàçíûå êîðîáî÷êè è íàçûâàòü ïî ðàçíîìó âìåñòî òîãî, ÷òîáû íàïèñàòü êàê ïðàâèëüíî äîçèðîâàòü äëÿ íîâîðîæäåííûõ... âîò âûäåðæêà èíñòðóêöèè ÁÖÆ îò Ìåðêà:

In infants less than 1 month old, the dosage of BCG VACCINE should be reduced by one-half, by using 2 mL of Sterile Water for Injection, U.S.P. at 4–25°C (39–77°F) when reconstituting. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

è íèêàêèõ ïîíòîâ ñ ÁÖÆ-Ì èëè "äîñòèæåíèå îòå÷åñòâåííîé íàó÷íîé ìûñëè"...

çàìåòüòå, èíñòðóêöèÿ ïðîñòî ñîîáùàåò î íàçíà÷åíèè ïîëîâèííîé äîçû â äàííîé âîçðàñòíîé ãðóïïå äåòåé, íî íå ïðèçûâàåò ê ëèáåðàëüíîìó ñíèæåíèþ äîçû âàêöèíàöèè ïî óñìîòðåíèþ âðà÷à èëè ìåäðàáîòíèêà, ïðîâîäÿù. âàêöèíàöèþ...
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #13  
Ñòàðûé 08.03.2012, 07:50
axt axt âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 03.08.2011
Ãîðîä: Ðîñòîâ-íà-Äîíó
Ñîîáùåíèé: 42
Ñêàçàë(à) ñïàñèáî: 12
axt *
Äà, åñòü íåêîòîðàÿ òîíêîñòü.
Îòâåòèòü ñ öèòèðîâàíèåì
  #14  
Ñòàðûé 08.03.2012, 07:52
axt axt âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 03.08.2011
Ãîðîä: Ðîñòîâ-íà-Äîíó
Ñîîáùåíèé: 42
Ñêàçàë(à) ñïàñèáî: 12
axt *
Ìîæåò áûòü óâàæàåìàÿ luidhen ïîäåëèòñÿ - êàêèå èññëåäîâàíèÿ îïðîâåðãàþò Êîðîëÿ è Ê?
Îòâåòèòü ñ öèòèðîâàíèåì
  #15  
Ñòàðûé 08.03.2012, 20:54
ÎëüãàØà ÎëüãàØà âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 11.02.2006
Ãîðîä: Ñ-Ïåòåðáóðã
Ñîîáùåíèé: 21,611
Ïîáëàãîäàðèëè 9,847 ðàç(à) çà 9,397 ñîîáùåíèé
ÎëüãàØà ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÎëüãàØà ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÎëüãàØà ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÎëüãàØà ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÎëüãàØà ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÎëüãàØà ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÎëüãàØà ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÎëüãàØà ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÎëüãàØà ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÎëüãàØà ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÎëüãàØà ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Äëÿ íà÷àëà õîòåëîñü áû âèäåòü íå ññûëêó íà áåëîðóññêóþ ðàáîòó, ññûëàþùóþñÿ â ñâîþ î÷åðåäü íà ðàáîòó Î. Êîðîëü (îíà, êñòàòè, äàìà), à êîíêðåòíóþ ÷àñòü ðàáîòû óïîìÿíóòîãî àâòîðà, äîêàçûâàþùóþ, ÷òî "Îïðåäåëåííàÿ ÷àñòü îñëîæíåíèé ñâÿçàíà êàê ðàç ñ ïðîâåäåíèåì äðóãèõ ïðèâèâîê íà ôîíå ëîêàëèçîâàííîãî, íî àêòèâíîãî òóáåðêóëåçíîãî ïðîöåññà â êîæå íà ìåñòå ââåäåíèÿ âàêöèíû ÁÖÆ".
Îòâåòèòü ñ öèòèðîâàíèåì
Îòâåò



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 03:50.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.